![John Maraganore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Maraganore
Président chez
HEMAB THERAPEUTICS HOLDINGS, INC.
Fortune : 2 M $ au 30/06/2026
Profil
John M. Maraganore est un homme d'affaires qui a été à la tête de 5 entreprises différentes. Le Dr Maraganore occupe le poste de directeur général et de directeur chez Alnylam Pharmaceuticals, Inc. Il est également membre du conseil d'administration de Biotechnology Innovation Organization (ancien président), Agios Pharmaceuticals, Inc. (ancien président) et de Tempero Pharmaceuticals, Inc. Dans sa carrière antérieure, il a occupé les postes de directeur chez MacroGenics, Inc. et Regulus Therapeutics, Inc. et de directeur du développement du marché et des affaires chez Biogen, Inc. directeur du marché et du développement commercial chez Biogen MA, Inc. et directeur de la biologie moléculaire et du développement commercial chez Biogen Idec, Inc. (Caroline du Nord) (toutes deux sont des filiales de Biogen, Inc.), conseiller stratégique chez Longwood Fund Management LLC, scientifique chez The Upjohn Co., premier vice-président chargé du développement stratégique des produits chez Millennium Pharmaceuticals, Inc. et scientifique chez ZymoGenetics, Inc. et partenaire de risque chez Third Rock Ventures GP LP. Le Dr Maraganore a obtenu un doctorat, un diplôme d'études supérieures et un diplôme de premier cycle à l'Université de Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 35 948 ( 0,08 % ) | 1 M $ | 30/06/2026 | |
| 10/07/2026 | 17 300 ( 0 % ) | 548 725 $ | 30/06/2026 | |
| 03/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
Prokidney Equity LLC
 Prokidney Equity LLC Medical/Nursing ServicesHealth Services Operates as a kidney centre -.--% | 11/07/2022 | 614 013 ( -.--% ) | - $ | Aujourd'hui |
| 24/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de John Maraganore
| Sociétés | Poste | Début |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2022 |
| BEAM THERAPEUTICS INC. | Directeur/Membre du Conseil | 05/11/2021 |
| BLACKSTONE INC. | Consultant / Advisor | 01/02/2022 |
| RAPPORT THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2024 |
| HEMAB THERAPEUTICS HOLDINGS, INC. | Président | 01/01/2022 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Directeur/Membre du Conseil | 01/06/2022 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 01/01/2022 |
Transcend Therapeutics
 Transcend Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage, neuroscience-focused company that develops rapid-acting treatments for neuropsychiatric diseases | Directeur/Membre du Conseil | - |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Consultant / Advisor | 01/09/2022 |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
| ░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de John Maraganore
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de John Maraganore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
39
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 39 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides alternative asset management services | Finance |
Third Rock Ventures GP LP | |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Molecular Biology Resources, Inc.
 Molecular Biology Resources, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures bio-chemicals | Process Industries |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
Entree Capital
 Entree Capital Investment ManagersFinance Entree Capital invests in companies located across the globe, primarily in Israel. The firm targets companies operating in the fields of SaaS, data, fintech, security, productivity and consumer. It provide financing for pre-seed, seed, early, later and buyout stage companies with an investment size of USD 0.25 - 3 million and also makes follow-on investments. | Finance |
Tempero Pharmaceuticals, Inc.
 Tempero Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develop next-generation therapies that selectively suppress Th17-cells and enhance specialized Treg cells | Commercial Services |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Ariadne Labs
 Ariadne Labs Hospital/Nursing ManagementHealth Services Provides hospital and healthcare services | Health Services |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
Termeer Foundation
 Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of transformative, patient-centered healthcare treatments. The private company is based in Boston. The foundation fosters a diverse, inclusive community of first-time CEOs, entrepreneurs, academics, and STEM students through values-driven leadership programs emphasizing responsibility, passion, creativity, humility, and connectivity. Key offerings include the Termeer Fellows Program for early-stage biotech CEOs, the Termeer Scholars Program for academic researchers translating discoveries into innovations, and support for STEM students. The foundation provides mentorship, executive coaching, strategic networking, and grants to cultivate leadership and collaboration across the life sciences sector. The American company was founded by Alan E. Walts. | Consumer Services |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Nucleate Bio, Inc. | |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Provides healthcare and biotechnology services | Health Technology |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | Commercial Services |
ProKidney Corp.
 ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
Transcend Therapeutics
Transcend Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage, neuroscience-focused company that develops rapid-acting treatments for neuropsychiatric diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
HEMAB THERAPEUTICS INC.
 HEMAB THERAPEUTICS INC. BiotechnologyHealth Technology Engages in research and development of prophylactic therapeutics for bleeding disorders | Health Technology |
